Quantitative three-dimensional analysis and diffusion modeling of oligonucleotide concentrations after direct intraparenchymal brain infusion

We compared quantitative experimental results on the diffusion of /sup 35/S-labeled phosphorothioate oligonucleotide (PS-ODN) after intraparenchymal infusion in rat brain, with the distributions predicted by Fick's second law of diffusion. Fischer 344 rats underwent identical intracerebral infusions of /sup 35/S-PS-ODN. After 0, 5, 11, 23, and 47 h, groups of animals were sacrificed and sequential brain cryosections subjected to autoradiography. The resulting experimental data were compared to the predicted distributions, for estimation of the apparent free diffusion coefficient, D*. Volumes of distribution and total content of /sup 35/S-PS-ODN in the parenchyma were also computed, to monitor loss of total material. The values for D* were within the expected range for the 21-mer PS-ODN used, but a progressive decrease in D* over time was noted. The model requires D* to remain constant and, thus, does not adequately explain the spread of /sup 35/S-PS-ODN following infusion. The progressive slowing of spread over time suggests that at later time points, /sup 35/S-PS-ODN may be fixed by tissue binding or cellular uptake in the brain. Loss of material via vascular and CSF clearance may also contribute to the lack of fit. Our results highlight issues to be addressed in the modeling and experimental design of the intraparenchymal infusion process.

[1]  C. Patlak,et al.  Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion. , 1975, The Journal of pharmacology and experimental therapeutics.

[2]  N. Tamaki,et al.  Biomechanics of hydrocephalus: a new theoretical model. , 1987, Neurosurgery.

[3]  R. Penn,et al.  Direct delivery of medication into a brain tumor through multiple chronically implanted catheters. , 1987, Neurosurgery.

[4]  C. Nicholson,et al.  Long distance pathways of diffusion for dextran along fibre bundles in brain. Relevance for volume transmission , 1995, Neuroreport.

[5]  Y. Nievergelt Fitting density functions and diffusion tensors to three-dimensional drug transport within brain tissue. , 1990 .

[6]  C. Nicholson,et al.  Quantitative analysis of extracellular space using the method of TMA+ iontophoresis and the issue of TMA+ uptake. , 1992, Canadian journal of physiology and pharmacology.

[7]  G. Aldis,et al.  Flow-induced deformation from pressurized cavities in absorbing porous tissues. , 1992, Bulletin of mathematical biology.

[8]  R. Diasio,et al.  Pharmacokinetics and tissue distribution in rats of an oligodeoxynucleotide phosphorothioate (GEM 91) developed as a therapeutic agent for human immunodeficiency virus type-1. , 1995, Biochemical pharmacology.

[9]  R K Jain,et al.  Transport of molecules in the tumor interstitium: a review. , 1987, Cancer research.

[10]  P F Morrison,et al.  Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion. , 1995, Journal of neurosurgery.

[11]  J Fenstermacher,et al.  Drug “Diffusion” within the Brain a , 1988, Annals of the New York Academy of Sciences.

[12]  W. Saltzman,et al.  Millimeter-scale positioning of a nerve-growth-factor source and biological activity in the brain. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[13]  W. Mark Saltzman,et al.  Distribution of nerve growth factor following direct delivery to brain interstitium , 1995, Brain Research.

[14]  V D Calhoun,et al.  A finite element model for predicting the distribution of drugs delivered intracranially to the brain. , 1997, The American journal of physiology.

[15]  G. Aldis,et al.  Comparison of models for flow induced deformation of soft biological tissue. , 1990, Journal of biomechanics.

[16]  W. Mark Saltzman,et al.  Drugs released from polymers: diffusion and elimination in brain tissue , 1991 .

[17]  H. Weiss,et al.  Increased Blood–Brain Permeability with Hyperosmolar Mannitol Increases Cerebral O2 Consumption and O2 Supply/Consumption Heterogeneity , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  C. Nicholson,et al.  Hindered diffusion of high molecular weight compounds in brain extracellular microenvironment measured with integrative optical imaging. , 1993, Biophysical journal.

[19]  Charles Nicholson,et al.  Ion-selective microelectrodes and diffusion measurements as tools to explore the brain cell microenvironment , 1993, Journal of Neuroscience Methods.

[20]  G T Gillies,et al.  Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells. , 1997, Neurosurgery.

[21]  E. Oldfield,et al.  Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice. , 1994, Journal of neurosurgery.

[22]  B. Chiasson,et al.  Infusion into the brain of an antisense oligonucleotide to the immediate-early gene c-fos suppresses production of Fos and produces a behavioral effect , 1994, Neuroscience.

[23]  R. Diasio,et al.  In vivo stability and disposition of a self-stabilized oligodeoxynucleotide phosphorothioate in rats. , 1995, Clinical chemistry.

[24]  W. Saltzman,et al.  Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain. , 1998, Cancer research.

[25]  P. Basser Interstitial pressure, volume, and flow during infusion into brain tissue. , 1992, Microvascular research.

[26]  A. Krieg,et al.  Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides. , 1994, Antisense research and development.

[27]  A. Friedman,et al.  Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. , 1991, Journal of neurosurgery.

[28]  G. Gillies,et al.  Distribution and stability of antisense phosphorothioate oligonucleotides in rodent brain following direct intraparenchymal controlled-rate infusion. , 1997, Journal of neurosurgery.

[29]  E. Oldfield,et al.  Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors , 1997, Nature Medicine.

[30]  D. Graves,et al.  The biophysics of DNA hybridization with immobilized oligonucleotide probes. , 1995, Biophysical journal.

[31]  S. Hakim,et al.  Biomechanics of hydrocephalus. , 1971, Acta neurologica latinoamericana.

[32]  R. Diasio,et al.  Absorption, tissue distribution and in vivo stability in rats of a hybrid antisense oligonucleotide following oral administration. , 1995, Biochemical pharmacology.

[33]  J. Chaires,et al.  Insights from a new analytical electrophoresis apparatus. , 1996, Journal of pharmaceutical sciences.

[34]  G T Gillies,et al.  Distribution of macromolecular dyes in brain using positive pressure infusion: a model for direct controlled delivery of therapeutic agents. , 1998, Surgical neurology.

[35]  Dillehay Le Decreasing resistance during fast infusion of a subcutaneous tumor. , 1997 .

[36]  R. Penn,et al.  Stereotactic administration of intratumoral chronic chemotherapy of recurrent malignant gliomas. , 1987, Applied neurophysiology.

[37]  P F Morrison,et al.  High-flow microinfusion: tissue penetration and pharmacodynamics. , 1994, The American journal of physiology.

[38]  P F Morrison,et al.  Transport of cisplatin in rat brain following microinfusion: an analysis. , 1986, Journal of pharmaceutical sciences.

[39]  E. Oldfield,et al.  Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with single-photon emission computerized tomography imaging. , 1997, Journal of neurosurgery.

[40]  J. Minna,et al.  Osmotic blood-brain barrier modification: monoclonal antibody, albumin, and methotrexate delivery to cerebrospinal fluid and brain. , 1985, Neurosurgery.

[41]  S. Agrawal,et al.  Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Nicolas de Tribolet,et al.  Outwitting the Blood-Brain Barrier for Therapeutic Purposes: Osmotic Opening and Other Means , 1998 .

[43]  C. Nicholson,et al.  Ion diffusion modified by tortuosity and volume fraction in the extracellular microenvironment of the rat cerebellum. , 1981, The Journal of physiology.

[44]  G T Gillies,et al.  Strategies for the design and delivery of antisense oligonucleotides in central nervous system. , 2000, Methods in enzymology.

[45]  S. Agrawal,et al.  Cellular uptake of oligodeoxynucleotide phosphorothioates and their analogs. , 1994, Antisense research and development.

[46]  J. Kroin Which Drugs, What Space? , 1988, Annals of the New York Academy of Sciences.

[47]  R. Penn,et al.  Intracerebral chemotherapy: chronic microinfusion of cisplatin. , 1982, Neurosurgery.

[48]  P F Morrison,et al.  Convection-enhanced delivery of macromolecules in the brain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Eva Syková,et al.  The Extracellular Space in the CNS: Its Regulation, Volume and Geometry in Normal and Pathological Neuronal Function , 1997 .

[50]  J. García de la Torre,et al.  Hydrodynamic properties of a double-helical model for DNA. , 1994, Biophysical journal.

[51]  C. Patlak,et al.  The Movements of Water and Solutes in the Brains of Mammals , 1976 .

[52]  R S Fisher,et al.  Local Perfusion of Diazepam Attenuates Interictal and Ictal Events in the Bicuculline Model of Epilepsy in Rats , 1997, Epilepsia.

[53]  R. Penn,et al.  Intratumoral Chemotherapy with Multiple Sources , 1988, Annals of the New York Academy of Sciences.

[54]  J. Tonkinson,et al.  Phosphorothioate oligodeoxynucleotides--anti-sense inhibitors of gene expression? , 1991, Pharmacology & therapeutics.

[55]  Charles Nicholson,et al.  Diffusion from an injected volume of a substance in brain tissue with arbitrary volume fraction and tortuosity , 1985, Brain Research.

[56]  H. Winn,et al.  Intracerebral drug delivery in rats with lesion-induced memory deficits. , 1989, Journal of neurosurgery.

[57]  V D Calhoun,et al.  A finite element model for predicting the distribution of drugs delivered intracranially to the brain. , 1997, American journal of physiology. Regulatory, integrative and comparative physiology.

[58]  L. Neckers,et al.  Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[59]  R K Jain,et al.  Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. , 1989, Microvascular research.

[60]  A. Marmarou,et al.  Clearance of brain edema and macromolecules through the cortical extracellular space. , 1992, Journal of neurosurgery.

[61]  Y. Cheng,et al.  Antisense oligonucleotides as therapeutic agents--is the bullet really magical? , 1993, Science.

[62]  J. Maizel,et al.  Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues. , 1989, Proceedings of the National Academy of Sciences of the United States of America.